ABNORMALITIES IN THE ULTRASTRUCTURE OF ALOPECIA HAIR FOLLICLES
T he cause of alopecia areata (AA) is not known. The favored hypothesis is that it results from an autoim mune response to hair follicles (HFs), based on indirect observations that have recently been re viewed [1] . These include the systemic nature of the disease, which may involve hair, eyes, and nails ; its association with other autoimmune diseases and autoantibodies to other organs; the presence of a lymphocytic infiltrate around and in hair bulbs during active disease; non-specific alterations in the number and/or func tion of circulating T cells; deposits of irrununoglobulin and com plement around HFs particularly at the edge of active lesions; increased expression of class I and II major histocompatibility complex antigens and of Langerhans cells in hair bulbs in active disease; and the fact that effective therapies for AA all have as a common denominator a suppression in dle number or function of irrunune cells in skin. The major problem with this hypothesis is that, until recently, there was no evidence of an abnormal immune response directed specifically to HFs in AA.
We recently have made tllree significant observations that strongly support the hypothesis that AA is an autoirrunune disease.
The first is that HFs express unique antigens, and tllat some of these are the target of autoimmune responses [2] . The presence of unique antigens in HFs was demonstrated by probing Western blots of extracts of isolated human HFs with sera of normal persons. Most individuals had low levels (titer of20) of antibodies that reacted to multiple antigens in HFs. Many of these antigens were specific for HF and were not expressed in adjacent epidermis or dermis. Unique H F-antigens extractable with NP-40 and 6 M urea had approxiInate Mw of84, 105, 115, and 125 kD and 115,145,200, and 220 kD, respectively. Most of these antigens were autoanti gens, as they reacted with antibodies present in the donor's own serum. The presence of unique antigens in HF that can trigger autoimmune responses provide the framework necessary to explain the selective damage to HF that occurs in AA.
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Second, antibodies to some antigens that are selectively ex pressed in HFs are present more frequently and in higher levels in patients with AA [3] . High-titer antibodies (>1:80) to HF were detected in all AA patients (100%) but in less than 44% of controls using a Western immunoblot assay [3] . The antibodies were predominantly directed to one or more antigens of approximately 44, 47, 50, 52, and 57 kD. The incidence of antibodies to these antigens in AA was up to seven times more frequent than in control sera and their level up to 13 times greater. The 44-52-kD antigens reacting witll AA antibodies were HF ' specific. All were expressed in HF extr acts, but could not be detected in similar extracts of adjacent scalp epidermis or dermis obtained from the same individ ual or other control tissues. By immunofluorescence some AA patients react with HF but not with adjacent epidermis or dermis confirming the presence of HF-specific antibodies in AA.
These diiferences were statistically significant for all five antigens . The nature of the HF antibody response in AA was further examined by analyzing the immunoglobulin isotype usage in AA and control persons. The anti-HF antibodies in control persons were present in low titer and were both IgM and IgG antibodies, whereas in AA the HF antibodies were high titer and predominantly IgG.
More recently, we have conducted studies to identify the sub set(s) of cells in HF that are the target(s) of immune responses in AA. We have developed methods to culture individually the maj or HF cell subpopulations including , for the first time, HF melano cytes [4] . We believe it is critical to use cells derived from HFs rather than cells of similar histologic type derived from epidermis to study immune abnormalities associated with AA, based on evidence that similar cells derived from these two sites are immunologically different. As a result, the use of cells derived from epidermis as targets in immune assays may fail to reveal immune responses directed specifically to cells of HF. TIrird, using isolated subsets ofHF cells as targets, we found that AA antibodies appear to be directed to both keratinocytes and melanocytes in HF. In these studies we studied the ability of antibodies in AA and control individuals to react to pure populations of keratinocytes and melanocytes derived from HF. Antibodies to HF keratinocytes, as-0022-202X/95/$09.50 • SSDIO022-202X(95)00109-X • Copyright © 1995 by The Society for Investigative Dermatology, Inc.
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sayed by immunoblotting, were present in all patients with AA. The antibodies were predominantly directed to one or more antigens of approximately 48-50, 52-54, 58-60, and 62-64 kD. Antibodies to the 58-60-kD and the 52-54-kD antigens were present in 80% and 86%, respectively of 49 patients with AA but in only 14% and 27% of 22 control individuals. These diJferences were statistically significant.
These antigens were expressed by keratinocytes derived from HF but could not be detected on keratinocytes derived from epidennis, indicating that keratinocytes in these two diJferent locations are antigenically diJferent. The incidence and level of HF keratinocyte antibodies correlated with disease severity. Patients with more severe disease (i.e., A. tota/is and A. universa/is) had a significantly higher incidence of antibodies to the 62-64-, 58-60-, and 48-50-kD HF keratinocyte antigens than patients with less severe patchy AA.
Preliminary results also suggest AA antibodies react to HF melanocytes. By indirect immunofluorescence, IgG antibodies to cytoplasmic antigens in fixed HF melanocytes were present in most AA patients (82%) but in only 10% of controls. The identity and specificity of the HF melanocytes antigens defined by AA antibod ies is currently under investigation.
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These results indicate that HF express unique antigens not found in adjacent scalp tissue, and that abnormal circulating antibodies to some HF-specific antigens are present in individ uals with AA. This provides the first direct evidence that abnormal immune responses specifically directed to antigens expressed only in HF are associated with AA. These findings strongly support the hypothesis that AA results from abnormal autoimmune responses to HF and can provide an explanation for the selective damage to HF that occurs in this disease.
[1]. These T lymphocytes invade the hair follicles and apparently interact with the hair-follicle cells. Such interaction may occur either by direct cell-to-cell contact and cytotoxicity, or indirectly by lymphokines that might affect the differentiation and growth of follicular epithelial cells. Because the T lymphocytes obviously do not promote cytotoxic activity we hypothesize that AA is triggered by soluble mediators that "switch off" the hair cycle, resulting in At present, topical immunotherapy with a potent contact allergen such as diphenylcyclopropenone (DCP) appears to be superior to other modes of treatment [2] . Why an allergic contact dermatitis is able to reverse the pathogenic process and induce hair regrowth is still unknown. If it is true that AA results from a distinct cytokine pattern, we can infer that the beneficial effect of DCP should be mediated by cytokines locally released during the contact allergy.
To address this question we performed a semiquantitative reverse transcriptase polymerase chain reaction [3] with RNA extracted from scalp biopsies that were obtained from patients with AA Reprint requests to: Dr. Rolf Hoffinann, Department of Dermatology, Philipp University, Deutschhausstra/3e 9, 35033 Marburg, Germany.
Abbreviations: DCP, diphenylcyclopropenone. before and after successful treatment with DCP, and from healthy controls. We detected a T-cell response with increased steady-state mRNA levels for IFN-,)" interleukin (IL)-l{3 and IL-2 in untreated AA of the totalis type. Mter DCP treatment we found increased mRNA steady-state levels for IL-2, IL-8, IL-l0, and TNF-O'. No transcripts for IL-4 were found, whereas IL-6 mRNA expression was low. IFN-')' and IL-l{3 transcripts were increased as compared to controls but, when compared to untreated AA, the overall expression level was reduced by 60% and 15% for IFN-')' and IL-l{3, respectively.
With our results we provide experimental evidence that cyto kines participate in the pathogenesis of AA. We detected increased lesional levels ofIFN-,)" IL-2, and IL-l{3 transcripts in scalp biopsies from patients with untreated AA, corresponding to a cytokine pattern of the Thl T -helper type. As IFN-')' is known to be crucially involved in adhesion molecule expression on hair follicles, our fmdings offer an explanation for the aberrant expression of mole cules such as ICAM-l and HLA-DR on affected hair follicles.
Furthermore, IL-l{3 has been shown to inhibit hair growth ill vitro
[4] , and our results suggest that IL-l {3 may trigger the harr growth arrest even ill vivo.
The pathways by which DCP therapy induces hair regrowth are unknown. However, we assume a substantial action of IL-l0. IL-10 has been characterized by its ability to inhibit Thl cytokine production. Several lines of evidence, however, indicate a more pleiotropic function of IL-l 0 as a modulator of immune responses [5 ] . If we assume that IL-l0 is involved in the induction of hair regrowth by DCP therapy, this hypothesis would explain the decreased expression of ICAM-l and HLA-DR molecules on hair-follicle keratinocytes. This hypothesis is supported by the 0022-202X/95/$09.50 • SSDI0022-202X(95)OOI10-7 • Copyright © 1995 by The Society for Investigative Dermatology, Inc.
